| 1 |
Lee, E. and Oh, J.E. (2021). Humoral immunity against SARS-CoV-2 and the impact on COVID-19 pathogenesis. Mol. Cells 44, 392-400./
|
|
| 2 |
Kim, T., Lee, J.S., and Ju, Y.S. (2021). Experimental models for SARS-CoV-2 infection. Mol. Cells 44, 377-383./
|
|
| 3 |
Jung, M.K. and Shin, E.C. (2021). Phenotypes and functions of SARS-CoV-2-reactive T cells. Mol. Cells 44, 401-407./
|
|
| 4 |
Park, S.H. (2021). An impaired inflammatory and innate immune response in COVID-19. Mol. Cells 44, 384-391./
|
|
| 5 |
Shah, M. and Woo, H.G. (2021). Molecular perspectives of SARS-CoV-2: pathology, immune evasion, and therapeutic interventions. Mol. Cells 44, 408-421./
|
|
| 6 |
Lee, S., Kim, J., and Park, J.E. (2021). Single-cell toolkits opening a new era for cell engineering. Mol. Cells 44, 127-135./
|
|
| 7 |
Le, D., Lim, S., Min, K.W., Park, J.W., Kim, Y., Ha, T., Moon, K.H., Wagner, K.U., and Kim, J.W. (2021). Tsg101 is necessary for the establishment and maintenance of mouse retinal pigment epithelial cell polarity. Mol. Cells 44, 168-178./
|
|
| 8 |
Chae, D., Han, S., Lee, M., and Kim, S. (2021). Genome edited Sirt1-overexpressing human mesenchymal stem cells exhibit therapeutic effects in treating collagen-induced arthritis. Mol. Cells 44, 245-253./
|
|
| 9 |
Kim, J., Ryu, S., and Kim, H.Y. (2021). Innate lymphoid cells in tissue homeostasis and disease pathogenesis. Mol. Cells 44, 301-309./
|
|
| 10 |
Kim, M.J., Lee, H.J., Choi, M.Y., Kang, S.S., Kim, Y.S., Shin, J.K., and Choi, W.S. (2021). UHRF1 induces methylation of the TXNIP promoter and down-regulates gene expression in cervical cancer. Mol. Cells 44, 146-159./
|
|